Omega Healthcare Investors (OHI) to Release Quarterly Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI) is expected to issue its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $0.79 per share and revenue of $287.1840 million for the quarter. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 10:00 AM ET.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. The business had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. During the same period in the previous year, the company earned $0.71 earnings per share. The business’s revenue for the quarter was up 14.4% on a year-over-year basis. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Omega Healthcare Investors Trading Down 1.8%

Shares of NYSE:OHI opened at $43.22 on Wednesday. The company has a quick ratio of 7.11, a current ratio of 7.11 and a debt-to-equity ratio of 0.95. Omega Healthcare Investors has a 52-week low of $35.04 and a 52-week high of $46.36. The stock has a market cap of $12.77 billion, a price-to-earnings ratio of 24.15, a PEG ratio of 1.42 and a beta of 0.57. The business has a 50-day moving average price of $44.66 and a 200-day moving average price of $42.39.

Analyst Ratings Changes

OHI has been the subject of several research reports. BMO Capital Markets cut shares of Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 price objective for the company. in a research note on Friday, January 9th. Weiss Ratings downgraded Omega Healthcare Investors from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Monday, January 12th. Royal Bank Of Canada boosted their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 6th. Citigroup reiterated a “buy” rating and set a $50.00 price target (up previously from $45.00) on shares of Omega Healthcare Investors in a report on Wednesday, November 12th. Finally, Truist Financial boosted their price target on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the company a “hold” rating in a research report on Monday, December 1st. Seven equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of “Moderate Buy” and an average price target of $47.09.

Insider Buying and Selling at Omega Healthcare Investors

In related news, CEO C Taylor Pickett purchased 20,000 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was bought at an average price of $43.14 per share, with a total value of $862,800.00. Following the completion of the transaction, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $862,800. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CIO Vikas Gupta purchased 11,500 shares of Omega Healthcare Investors stock in a transaction on Thursday, November 6th. The shares were acquired at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the purchase, the executive owned 13,773 shares in the company, valued at approximately $591,825.81. This trade represents a 505.94% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. CIBC Private Wealth Group LLC raised its stake in Omega Healthcare Investors by 85.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 9,296 shares of the real estate investment trust’s stock valued at $392,000 after purchasing an additional 4,292 shares during the period. CIBC Bancorp USA Inc. purchased a new position in shares of Omega Healthcare Investors during the third quarter valued at $3,273,000. Captrust Financial Advisors raised its position in Omega Healthcare Investors by 9.0% during the third quarter. Captrust Financial Advisors now owns 63,922 shares of the real estate investment trust’s stock valued at $2,699,000 after buying an additional 5,293 shares during the period. Coldstream Capital Management Inc. lifted its stake in Omega Healthcare Investors by 2.4% in the 3rd quarter. Coldstream Capital Management Inc. now owns 62,382 shares of the real estate investment trust’s stock worth $2,634,000 after acquiring an additional 1,458 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in Omega Healthcare Investors in the 3rd quarter worth about $84,000. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.